Calnexin anticorps (C-Term)
Aperçu rapide pour Calnexin anticorps (C-Term) (ABIN2962108)
Antigène
Voir toutes Calnexin (CANX) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Reacts with the C-terminal part of human CANX
-
Réactivité croisée
- Souris, Chien
-
Réactivité croisée (Details)
- Cross-reacts with mouse, rat, monkey and canine protein.
-
Purification
- Antigen affinity purified
-
Immunogène
- Recombinant protein fragment corresponding to the carboxy terminus of human CANX produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IF: 1:50 - 1:500 IHC - P: 5 μg/mL WB: 1:500 - 1:2000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2 mg/mL
-
Buffer
- PBS, glycerol 20 % , Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at +4°C for short-term storage. Aliquot and store at -20°C for long-term storage. Avoid repeated freezing and thawing.
-
-
- Calnexin (CANX)
-
Autre désignation
- CANX
-
ID gène
- 821
-
Pathways
- Signalisation MAPK, Thyroid Hormone Synthesis
Antigène
-